Tag:
biomarker discovery
Latest Headlines
Latest Headlines
Targeted therapies need cost-effective biomarkers
Biomarker discovery and development are driving the development of targeted therapies, particularly in cancer, and these need companion tests to ensure that only the people with the right markers (and therefore the people who are most likely to benefit) are treated. But what does it cost?
Clinical use of biomarkers growing fast in oncology, cardiology
Nearly 90% of all candidate drugs fail in clinical trials. That's just the nature of clinical development. Lots of failures due to issues involving toxicity and absorption. But wouldn't it be nice to
Authors: Better toolbox, standards will bring biomarkers to clinic
Embedded in a feature story on diagnostic microchips, Texas CEO magazine makes a compelling case for the reasons behind biomarkers' seeming inability to transfer quickly enough from lab to clinic.
How to break biomarkers through barrier between lab, clinic
Alan Dove, contributing editor to Drug Discovery & Development, reports on efforts to break the barriers that separate laboratory successes in identifying biomarkers to actual validation and
